Distinctive Under-Expression Profile of Inflammatory and Redox Genes in the Blood of Elderly Patients with Cardiovascular Disease

References

• Franceschi C, Garagnani P, Parini P, Giuliani C, Santoro A. Inflammaging: a new immune–metabolic viewpoint for age-related diseases. Nat Rev Endocrinol. 2018;14(10):576–590. doi:10.1038/s41574-018-0059-4
   PubMed Web of Science ®Google Scholar
• Siti HN, Kamisah Y, Kamsiah J. The role of oxidative stress, antioxidants and vascular inflammation in cardiovascular disease (a review). Vascul Pharmacol. 2015;71:40–56. doi:10.1016/j.vph.2015.03.005
   PubMed Web of Science ®Google Scholar
• Guzik TJ, Touyz RM. Oxidative stress, inflammation, and vascular aging in hypertension. Hypertension. 2017;70(4):660–667. doi:10.1161/HYPERTENSIONAHA.117.07802
   PubMed Web of Science ®Google Scholar
• Klisic A, Isakovic A, Kocic G, et al. Relationship between oxidative stress, inflammation and dyslipidemia with fatty liver index in patients with Type 2 diabetes mellitus. Exp Clin Endocrinol Diabetes. 2018;126(06):371–378. doi:10.1055/s-0043-118667
   PubMedGoogle Scholar
• Miljkovic M, Stefanovic A, Simic-Ogrizovic S, et al. Association of dyslipidemia, oxidative stress, and inflammation with redox status in VLDL, LDL, and HDL lipoproteins in patients with renal disease. Angiology. 2018;69(10):861–870. doi:10.1177/0003319718780041
   PubMed Web of Science ®Google Scholar
• Campisi J. Aging, cellular senescence, and cancer. Annu Rev Physiol. 2013;75(1):685–705. doi:10.1146/annurev-physiol-030212-183653
   PubMedGoogle Scholar
• Payne BAI, Chinnery PF. Mitochondrial dysfunction in aging: much progress but many unresolved questions. Biochim Biophys Acta Bioenerg. 2015;1847(11):1347–1353. doi:10.1016/j.bbabio.2015.05.022
   PubMed Web of Science ®Google Scholar
• Cuervo AM. Autophagy and aging: keeping that old broom working. Trends Genet. 2008;24(12):604–612. doi:10.1016/j.tig.2008.10.002
   PubMed Web of Science ®Google Scholar
• Marín-Aguilar F, Ruiz-Cabello J, Cordero MD. Aging and the Inflammasomes. Exp Suppl. 2018;108:303–320. doi:10.1007/978-3-319-89390-7_13
   Google Scholar
• Saez I, Vilchez D. The mechanistic links between proteasome activity, aging and age-related diseases. Curr Genomics. 2014;15(1):38–51. doi:10.2174/138920291501140306113344
   PubMed Web of Science ®Google Scholar
• Wang C, Jurk D, Maddick M, Nelson G, Martin-Ruiz C, Von Zglinicki T. DNA damage response and cellular senescence in tissues of aging mice. Aging Cell. 2009;8(3):311–323. doi:10.1111/j.1474-9726.2009.00481.x
   PubMed Web of Science ®Google Scholar
• Kamo T, Akazawa H, Suda W, et al. Dysbiosis and compositional alterations with aging in the gut microbiota of patients with heart failure. Bando Y, ed. PLoS One. 2017;12(3):e0174099. doi:10.1371/journal.pone.0174099
   PubMed Web of Science ®Google Scholar
• Tilstra JS, Clauson CL, Niedernhofer LJ, Robbins PD. NF-κB in aging and disease. Aging Dis. 2011;2(6):449–465.
   PubMed Web of Science ®Google Scholar
• Coppé J-P, Patil CK, Rodier F, et al. A human-like senescence-associated secretory phenotype is conserved in mouse cells dependent on physiological oxygen. Blagosklonny M V., ed. PLoS One. 2010;5(2):e9188. doi:10.1371/journal.pone.0009188
   PubMed Web of Science ®Google Scholar
• Hishikawa A, Hayashi K, Itoh H. Transcription Factors as Therapeutic Targets in Chronic Kidney Disease. Molecules. 2018;23(5):1123. doi:10.3390/molecules23051123
   PubMed Web of Science ®Google Scholar
• Papaconstantinou J. The role of signaling pathways of inflammation and oxidative stress in development of senescence and aging phenotypes in cardiovascular disease. Cells. 2019;8(11):1383. doi:10.3390/cells8111383
   PubMed Web of Science ®Google Scholar
• Liguori I, Russo G, Curcio F, et al. Oxidative stress, aging, and diseases. Clin Interv Aging. 2018;13:757–772. doi:10.2147/CIA.S158513
   PubMed Web of Science ®Google Scholar
• Furman D, Campisi J, Verdin E, et al. Chronic inflammation in the etiology of disease across the life span. Nat Med. 2019;25(12):1822–1832. doi:10.1038/s41591-019-0675-0
   PubMed Web of Science ®Google Scholar
• IJsselmuiden AJ, Musters RJ, de Ruiter G, et al. Circulating white blood cells and platelets amplify oxidative stress in heart failure. Nat Clin Pract Cardiovasc Med. 2008;5(12):811–820. doi:10.1038/ncpcardio1364
   PubMedGoogle Scholar
• Xie F, Xiao P, Chen D, Xu L, Zhang B. miRDeepFinder: a miRNA analysis tool for deep sequencing of plant small RNAs. Plant Mol Biol. 2012;80(1):75–84. doi:10.1007/s11103-012-9885-2
   Web of Science ®Google Scholar
• Cheng Q, Cant CA, Moll T, et al. NK-kappa B subunit-specific regulation of the I kappa B alpha promoter. J Biol Chem. 1994;269(18):13551–13557. doi:10.1016/S0021-9258(17)36866-7
   PubMed Web of Science ®Google Scholar
• Huang TT, Miyamoto S. Postrepression activation of NF-κB requires the amino-terminal nuclear export signal specific to IκBα. Mol Cell Biol. 2001;21(14):4737–4747. doi:10.1128/MCB.21.14.4737-4747.2001
   PubMed Web of Science ®Google Scholar
• Mathes E, O’Dea EL, Hoffmann A, Ghosh G. NF-κB dictates the degradation pathway of IκBα. EMBO J. 2008;27(9):1357–1367. doi:10.1038/emboj.2008.73
   PubMed Web of Science ®Google Scholar
• Gordon JW, Shaw JA, Kirshenbaum LA. Multiple Facets of NF-κB in the heart. Circ Res. 2011;108(9):1122–1132. doi:10.1161/CIRCRESAHA.110.226928
   PubMed Web of Science ®Google Scholar
• Liu T, Zhang L, Joo D, Sun S-C. NF-κB signaling in inflammation. Signal Transduct Target Ther. 2017;2(1):17023. doi:10.1038/sigtrans.2017.23
   PubMed Web of Science ®Google Scholar
• Dorrington MG, Fraser IDC. NF-κB signaling in macrophages: dynamics, crosstalk, and signal integration. Front Immunol. 2019;10. doi:10.3389/fimmu.2019.00705.
   PubMed Web of Science ®Google Scholar
• Nelson RH, Nelson DE. Signal distortion: how intracellular pathogens alter host cell fate by modulating NF-κB dynamics. Front Immunol. 2018;9. doi:10.3389/fimmu.2018.02962.
   Web of Science ®Google Scholar
• Hernandez A, Burger M, Blomberg BB, et al. Inhibition of NF-κB during human dendritic cell differentiation generates anergy and regulatory T-cell activity for one but not two human leukocyte antigen DR mismatches. Hum Immunol. 2007;68(9):715–729. doi:10.1016/j.humimm.2007.05.010
   PubMed Web of Science ®Google Scholar
• Sun S-C. The non-canonical NF-κB pathway in immunity and inflammation. Nat Rev Immunol. 2017;17(9):545–558. doi:10.1038/nri.2017.52
   PubMed Web of Science ®Google Scholar
• Du K, Tsichlis PN. Regulation of the Akt kinase by interacting proteins. Oncogene. 2005;24(50):7401–7409. doi:10.1038/sj.onc.1209099
   PubMed Web of Science ®Google Scholar
• Bai D, Ueno L, Vogt PK. Akt-mediated regulation of NFκB and the essentialness of NFκB for the oncogenicity of PI3K and Akt. Int J Cancer. 2009;125(12):2863–2870. doi:10.1002/ijc.24748
   PubMed Web of Science ®Google Scholar
• Iwanaszko M, Kimmel M. NF-κB and IRF pathways: cross-regulation on target genes promoter level. BMC Genomics. 2015;16(1):307. doi:10.1186/s12864-015-1511-7
   PubMedGoogle Scholar
• Balachandran S, Beg AA. Defining emerging roles for NF-κB in antivirus responses: revisiting the interferon-β enhanceosome paradigm. Rall GF, ed. PLoS Pathog. 2011;7(10):e1002165. doi:10.1371/journal.ppat.1002165
   PubMed Web of Science ®Google Scholar
• Roumeliotis AK, Roumeliotis SK, Panagoutsos SA, et al. Association of ALOX12 gene polymorphism with all-cause and cardiovascular mortality in diabetic nephropathy. Int Urol Nephrol. 2018;50(2):321–329. doi:10.1007/s11255-017-1755-z
   PubMed Web of Science ®Google Scholar
• Dobrian AD, Lieb DC, Cole BK, Taylor-Fishwick DA, Chakrabarti SK, Nadler JL. Functional and pathological roles of the 12- and 15-lipoxygenases. Prog Lipid Res. 2011;50(1):115–131. doi:10.1016/j.plipres.2010.10.005
   PubMed Web of Science ®Google Scholar
• Porro B, Songia P, Squellerio I, Tremoli E, Cavalca V. Analysis, physiological and clinical significance of 12-HETE: A neglected platelet-derived 12-lipoxygenase product. J Chromatogr B. 2014;964:26–40. doi:10.1016/j.jchromb.2014.03.015
   PubMed Web of Science ®Google Scholar
• Humphries ESA, Dart C. Neuronal and cardiovascular potassium channels as therapeutic drug targets. J Biomol Screen. 2015;20(9):1055–1073. doi:10.1177/1087057115601677
   PubMedGoogle Scholar
• Awtry EH, Loscalzo J. Aspirin. Circulation. 2000;101(10):1206–1218. doi:10.1161/01.CIR.101.10.1206
   PubMed Web of Science ®Google Scholar
• Matthay MA. Severe sepsis — a new treatment with both anticoagulant and antiinflammatory properties. N Engl J Med. 2001;344(10):759–762. doi:10.1056/NEJM200103083441009
   PubMed Web of Science ®Google Scholar
• Ikei KN, Yeung J, Apopa PL, et al. Investigations of human platelet-type 12-lipoxygenase: role of lipoxygenase products in platelet activation. J Lipid Res. 2012;53(12):2546–2559. doi:10.1194/jlr.M026385
   PubMed Web of Science ®Google Scholar
• Iñiguez MA, Cacheiro-Llaguno C, Cuesta N, Díaz-Muñoz MD, Fresno M. Prostanoid function and cardiovascular disease. Arch Physiol Biochem. 2008;114(3):201–209. doi:10.1080/13813450802180882
   PubMedGoogle Scholar
• Stables MJ, Newson J, Ayoub SS, Brown J, Hyams CJ, Gilroy DW. Priming innate immune responses to infection by cyclooxygenase inhibition kills antibiotic-susceptible and -resistant bacteria. Blood. 2010;116(16):2950–2959. doi:10.1182/blood-2010-05-284844
   PubMed Web of Science ®Google Scholar
• Mashima R, Okuyama T. The role of lipoxygenases in pathophysiology; new insights and future perspectives. Redox Biol. 2015;6:297–310. doi:10.1016/j.redox.2015.08.006
   PubMed Web of Science ®Google Scholar
• Nauseef WM. Myeloperoxidase in human neutrophil host defence. Cell Microbiol. 2014;16(8):1146–1155. doi:10.1111/cmi.12312
   PubMed Web of Science ®Google Scholar
• Ndrepepa G. Myeloperoxidase – a bridge linking inflammation and oxidative stress with cardiovascular disease. Clin Chim Acta. 2019;493:36–51. doi:10.1016/j.cca.2019.02.022
   PubMed Web of Science ®Google Scholar
• Rudolph TK, Wipper S, Reiter B, et al. Myeloperoxidase deficiency preserves vasomotor function in humans. Eur Heart J. 2012;33(13):1625–1634. doi:10.1093/eurheartj/ehr193
   PubMed Web of Science ®Google Scholar
• Panday A, Sahoo MK, Osorio D, Batra S. NADPH oxidases: an overview from structure to innate immunity-associated pathologies. Cell Mol Immunol. 2015;12(1):5–23. doi:10.1038/cmi.2014.89
   PubMed Web of Science ®Google Scholar
• Donkó Á, Péterfi Z, Sum A, Leto T, Geiszt M. Dual oxidases. Philos Trans R Soc B Biol Sci. 2005;360(1464):2301–2308. doi:10.1098/rstb.2005.1767
   PubMed Web of Science ®Google Scholar
• Joo J-H, Ryu J-H, Kim C-H, et al. Dual oxidase 2 is essential for the toll-like receptor 5-mediated inflammatory response in Airway Mucosa. Antioxid Redox Signal. 2012;16(1):57–70. doi:10.1089/ars.2011.3898
   PubMed Web of Science ®Google Scholar
• van der Vliet A, Danyal K, Heppner DE. Dual oxidase: a novel therapeutic target in allergic disease. Br J Pharmacol. 2018;175(9):1401–1418. doi:10.1111/bph.14158
   PubMed Web of Science ®Google Scholar
• Ha E-M, Lee K-A, Seo YY, et al. Coordination of multiple dual oxidase–regulatory pathways in responses to commensal and infectious microbes in drosophila gut. Nat Immunol. 2009;10(9):949–957. doi:10.1038/ni.1765
   PubMed Web of Science ®Google Scholar
• Yang HT, Huang YH, Yang GW. Mini review: immunologic functions of dual oxidases in mucosal systems of vertebrates. Braz J Biol. 2019. doi:10.1590/1519-6984.208749
   Web of Science ®Google Scholar
• Sarr D, Tóth E, Gingerich A, Rada B. Antimicrobial actions of dual oxidases and lactoperoxidase. J Microbiol. 2018;56(6):373–386. doi:10.1007/s12275-018-7545-1
   PubMed Web of Science ®Google Scholar
• Berndt C, Lillig CH, Holmgren A. Thiol-based mechanisms of the thioredoxin and glutaredoxin systems: implications for diseases in the cardiovascular system. Am J Physiol Circ Physiol. 2007;292(3):H1227–H1236. doi:10.1152/ajpheart.01162.2006
   PubMed Web of Science ®Google Scholar
• Yoshihara E, Masaki S, Matsuo Y, Chen Z, Tian H, Yodoi J. Thioredoxin/Txnip: redoxisome, as a redox switch for the pathogenesis of diseases. Front Immunol. 2014;4. doi:10.3389/fimmu.2013.00514.
   PubMed Web of Science ®Google Scholar
• Calabrese V, Cornelius C, Cuzzocrea S, Iavicoli I, Rizzarelli E, Calabrese EJ. Hormesis, cellular stress response and vitagenes as critical determinants in aging and longevity. Mol Aspects Med. 2011;32(4–6):279–304. doi:10.1016/j.mam.2011.10.007
   PubMed Web of Science ®Google Scholar
• Korbelik M, Sun J, Cecic I. Photodynamic therapy-induced cell surface expression and release of heat shock proteins: relevance for tumor response. Cancer Res. 2005;65(3):1018–1026.
   PubMed Web of Science ®Google Scholar
• Aridon P, Geraci F, Turturici G, D’Amelio M, Savettieri G, Sconzo G. Protective role of heat shock proteins in Parkinson’s disease. Neurodegener Dis. 2011;8(4):155–168. doi:10.1159/000321548
   PubMed Web of Science ®Google Scholar
• Jiang B, Moskovitz J. The functions of the mammalian methionine sulfoxide reductase system and related diseases. Antioxidants. 2018;7(9):122. doi:10.3390/antiox7090122
   Web of Science ®Google Scholar
• Drazic A, Miura H, Peschek J, et al. Methionine oxidation activates a transcription factor in response to oxidative stress. Proc Natl Acad Sci. 2013;110(23):9493–9498. doi:10.1073/pnas.1300578110
   PubMed Web of Science ®Google Scholar
• Krishna S, Miller LS. Innate and adaptive immune responses against Staphylococcus aureus skin infections. Semin Immunopathol. 2012;34(2):261–280. doi:10.1007/s00281-011-0292-6
   PubMed Web of Science ®Google Scholar
• Perkins ND. Post-translational modifications regulating the activity and function of the nuclear factor kappa B pathway. Oncogene. 2006;25(51):6717–6730. doi:10.1038/sj.onc.1209937
   PubMed Web of Science ®Google Scholar
• Morgan MJ, Liu Z. Crosstalk of reactive oxygen species and NF-κB signaling. Cell Res. 2011;21(1):103–115. doi:10.1038/cr.2010.178
   PubMed Web of Science ®Google Scholar
• García N, Zazueta C, Aguilera-Aguirre L. Oxidative stress and inflammation in cardiovascular disease. Oxid Med Cell Longev. 2017;2017:1–2. doi:10.1155/2017/5853238
   Web of Science ®Google Scholar
• Kattoor AJ, Pothineni NVK, Palagiri D, Mehta JL. Oxidative stress in atherosclerosis. Curr Atheroscler Rep. 2017;19(11):42. doi:10.1007/s11883-017-0678-6
   PubMed Web of Science ®Google Scholar
• Nakamura K, Murakami M, Miura D, et al. Beta-blockers and oxidative stress in patients with heart failure. Pharmaceuticals. 2011;4(8):1088–1100. doi:10.3390/ph4081088
   Google Scholar
• Munzel T, Keaney JF. Are ACE inhibitors a “Magic Bullet” against oxidative stress? Circulation. 2001;104(13):1571–1574. doi:10.1161/hc3801.095585
   PubMed Web of Science ®Google Scholar
• Kortekaas KE, Meijer CA, Hinnen JW, et al. ACE inhibitors potently reduce vascular inflammation, results of an open proof-of-concept study in the abdominal aortic aneurysm. Norata GD, ed. PLoS One. 2014;9(12):e111952. doi:10.1371/journal.pone.0111952
   PubMed Web of Science ®Google Scholar
• Kunsch C, Medford RM. Oxidative stress as a regulator of gene expression in the vasculature. Circ Res. 1999;85(8):753–766. doi:10.1161/01.RES.85.8.753
   PubMed Web of Science ®Google Scholar
• Priya Dharshini LC, Vishnupriya S, Sakthivel KM, Rasmi RR. Oxidative stress responsive transcription factors in cellular signalling transduction mechanisms. Cell Signal. 2020;72:109670. doi:10.1016/j.cellsig.2020.109670
   PubMed Web of Science ®Google Scholar